Brief: Osmotica Pharmaceuticals PLC Reports Third Quarter 2021 Results And Provides Business Update
15/11/2021 21:22
Nov 15 (Reuters) - Osmotica Pharmaceuticals PLC OSMT.O :
* REPORTS THIRD QUARTER 2021 RESULTS AND PROVIDES BUSINESS
UPDATE
* Q3 REVENUE $2.2 MILLION VERSUS $25.8 MILLION
* QTRLY BASIC AND DILUTED LOSS PER SHARE $0.28
Source text for Eikon: ID:nGNX2BLwW0
Further company coverage: OSMT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RVL Pharmaceuticals
See all newsBrief: RVL Pharmaceuticals Says High Court Of Ireland Made A Winding Up Order In Respect Of Co On Feb 12
Brief: RVL Pharmaceuticals Says Co Issued Petition In Central Office Of High Court In Ireland To Wind Up Company
Brief: RVL Completes Financial Restructuring
Brief: Rvl Pharmaceuticals PLC Received Delisting Notice From Listing Qualifications Department Of Nasdaq Stock Market Llc
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius